These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13884314)

  • 21. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral kala-azar associated with post-kala-azar dermal leishmaniasis.
    Singh NK; Agrawal SK; Jha TK
    J Assoc Physicians India; 1989 Feb; 37(2):191. PubMed ID: 2808294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kala-azar].
    HERTWIG F; OBERDOERSTER F
    Z Tropenmed Parasitol; 1960 Dec; 11():401-9. PubMed ID: 13713816
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
    Shah H
    JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinico-epidemiological profiles of post-kala-azar dermal leishmaniasis in Varanasi.
    Rai RN; Kumar M; Srivastava A; Joshi RD; Asthana AK; Tripathi VC; Dutta KK
    J Commun Dis; 1989 Sep; 21(3):214-7. PubMed ID: 2614049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short communication: post-kala-azar dermal leishmaniasis--an appraisal.
    Ramesh V; Singh R; Salotra P
    Trop Med Int Health; 2007 Jul; 12(7):848-51. PubMed ID: 17596251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Visceral leishmaniasis (kala-azar) in Germany].
    Meissner W; Seybold G
    Med Welt; 1966 Jan; 1():48-52. PubMed ID: 5942364
    [No Abstract]   [Full Text] [Related]  

  • 29. [Kala azar and cutaneous leishmaniasis in Yugoslavia].
    TODOROVIC K
    Zentralbl Bakteriol Orig; 1957 Jan; 167(5):390-5. PubMed ID: 13423624
    [No Abstract]   [Full Text] [Related]  

  • 30. Newer strategies for the kala-azar elimination programme in India.
    Thakur CP; Meenakshi Thakur AK; Thakur S
    Indian J Med Res; 2009 Jan; 129(1):102-4. PubMed ID: 19287067
    [No Abstract]   [Full Text] [Related]  

  • 31. [Kala-azar in Turkey. Its relationship to canine leishmaniasis].
    Yasarol S
    Ann Parasitol Hum Comp; 1965; 40(6):643-50. PubMed ID: 5893481
    [No Abstract]   [Full Text] [Related]  

  • 32. Kala azar in an adult Libyan and review of visceral leishmaniasis in Libya.
    Jain S; el Mangoush MA; el-Bouri K; Mahfouz MO
    Trop Geogr Med; 1990 Jul; 42(3):283-5. PubMed ID: 2293439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary survey of domestic animal visceral leishmaniasis and risk factors in north-west Ethiopia.
    Kenubih A; Dagnachew S; Almaw G; Abebe T; Takele Y; Hailu A; Lemma W
    Trop Med Int Health; 2015 Feb; 20(2):205-10. PubMed ID: 25327874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of visceral leishmaniasis (kala-azar)].
    Hromec A; Duris I; Hollý D
    Bratisl Lek Listy; 1967; 48(11):667-74. PubMed ID: 5584031
    [No Abstract]   [Full Text] [Related]  

  • 35. [Kala-azar in China from 1985 to 1988. Advisory Committee on Parasitic Diseases, MOPH].
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1989; 7(3):161-2. PubMed ID: 2591032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Survey on a new case of visceral leishmaniasis in Shanxi Province].
    Cai HX; Zuo SJ; Xu WX; Wu WP; Li J; Xu KJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Jun; 30(3):188-90. PubMed ID: 23072132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Visceral leishmaniasis or kala-azar: the epidemiological and control aspects].
    Vieira JB; Coelho GE
    Rev Soc Bras Med Trop; 1998; 31 Suppl 2():85-92. PubMed ID: 10444973
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new focus of kala-azar in Aïr (Niger)].
    Doury P
    Med Trop (Mars); 1989; 49(1):81-2. PubMed ID: 2725250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kala-azar in Varanasi (UP)--preliminary observations.
    Rai RN; Sehgal PN
    J Commun Dis; 1990 Jun; 22(2):120-3. PubMed ID: 2098410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.